News

Venture Challenge Fall 2022 Now open for applications!

4 May 2022 The proven Venture Challenge coaching programme focuses on developing your initial idea into a solid business case with boot camps, 1-on-1 coaching and mentoring.

Meet the teams of the Venture Challenge Spring 2022

2 May 2022 Last week five teams started their Venture Challenge adventure. In the first three-day workshop the highly motivated teams worked on their customer value proposition, long-term vision and competitive positioning.

Quell Therapeutics and Cellistic™ enter a strategic collaboration

29 April 2022 After Ncardia launched its affiliate company Cellistic last week, dedicated to making large-scale allogeneic cell therapy production a reality, they are proud to now enter a strategic collaboration with Quell Therapeutics, to develop an iPSC-derived allogeneic T-regulatory cell therapy platform.

Yesterday an Inspiring MedtechMeeting Took Place!

29 April 2022 MedtechPartners is a strong network of experts in the medical technology industry. At this meeting, promising start-ups pitched their innovation and were matched to the partners and audience. The MedtechMeeting ended with networking drinks. All in all it was a great succes!

Anya Biotech wins the Proefdiervrij Venture Challenge 2022

26 April 2022 The Hague - 22 April 2022. At the Proefdiervrij Event Anya Biotech was announced the winner of the 2nd edition of the Proefdiervrij Venture Challenge. Harsha Devalla, Marc Roelofs and Sander van Leeuwe of Anya Biotech develop animal-free re

Venture Challenge Fall 2022 open for applications!

26 April 2022 Curious what the Venture Challenge may bring you? This is what last year's alumni say about it.

STENTiT raises €1.8 Million in Seed Round

25 April 2022 Eindhoven, The Netherlands, 25 April 2022 – Venture Challenge alumnus STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases, has closed a €1.8 million see